For sure, there is no free lunch at the market and everybody must accept a fluctuating stock price. But in my view, there are different ways to take risk. Some are natural and others are not calculable risks, created by the company or the environment in which the corporate acts.
Let’s come back to my value stock screener. I would like to try out the Low P/B Companies screener by gurufocus and I’m glad to share the top yielding results with you here.
The screener supports only stocks that have grown sales and earnings over the past decade consistently. They are somehow predictable and high-quality stocks. The screener compares the current P/B ratios with the 10-Year average values of the ratio and plots the top 25 companies with the lowest spreads.
Only eight stocks of the top 25 results have a yield over 2 percent and three of them got a buy or better rating.
Here are the best yielding stocks from the screen:
If you would like to receive more dividend stock ideas and the free Dividend Weekly, you should subscribe to my free e-mail list. Alternatively, you can follow me on Facebook or Twitter.
China Petroleum & Chemical (NYSE:SNP) has a market capitalization of $70.16 billion. The company employs 376,201 people, generates revenue of $455.206 billion and has a net income of $10.913 billion. China Petroleum & Chemical’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $27.816 billion. The EBITDA margin is 6.11 percent (the operating margin is 3.54 percent and the net profit margin 2.40 percent).
Financial Analysis: The total debt represents 21.95 percent of China Petroleum & Chemical’s assets and the total debt in relation to the equity amounts to 54.43 percent. Due to the financial situation, a return on equity of 12.99 percent was realized by China Petroleum & Chemical. Twelve trailing months earnings per share reached a value of $8.90. Last fiscal year, China Petroleum & Chemical paid $3.77 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 8.59, the P/S ratio is 0.19 and the P/B ratio is finally 0.84. The dividend yield amounts to 5.18 percent and the beta ratio has a value of 0.83.
 |
| Long-Term Stock Price Chart Of China Petroleum & Chemical (SNP) |
 |
| Long-Term Dividend Payment History of China Petroleum & Chemical (SNP) |
 |
| Long-Term Dividend Yield History of China Petroleum & Chemical (SNP) |
Compania de Minas Buenaventura (NYSE:BVN) has a market capitalization of $3.23 billion. The company employs 2,647 people, generates revenue of $1.563 billion and has a net income of $742.79 million. Compania de Minas Buenaventura’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $544.89 million. The EBITDA margin is 34.85 percent (the operating margin is 26.75 percent and the net profit margin 47.51 percent).
Financial Analysis: The total debt represents 3.91 percent of Compania de Minas Buenaventura’s assets and the total debt in relation to the equity amounts to 4.84 percent. Due to the financial situation, a return on equity of 19.90 percent was realized by Compania de Minas Buenaventura. Twelve trailing months earnings per share reached a value of $1.76. Last fiscal year, Compania de Minas Buenaventura paid $0.60 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 7.25, the P/S ratio is 2.28 and the P/B ratio is finally 0.87. The dividend yield amounts to 3.93 percent and the beta ratio has a value of 0.72.
 |
| Long-Term Stock Price Chart Of Compania de Minas Buenaventura (BVN) |
 |
| Long-Term Dividend Payment History of Compania de Minas Buenaventura (BVN) |
 |
| Long-Term Dividend Yield History of Compania de Minas Buenaventura (BVN) |
Teva Pharmaceutical Industries (NYSE:TEVA) has a market capitalization of $32.41 billion. The company employs 45,948 people, generates revenue of $20.317 billion and has a net income of $1.956 billion. Teva Pharmaceutical’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6.055 billion. The EBITDA margin is 29.80 percent (the operating margin is 10.85 percent and the net profit margin 9.63 percent).
Financial Analysis: The total debt represents 29.08 percent of Teva Pharmaceutical’s assets and the total debt in relation to the equity amounts to 64.64 percent. Due to the financial situation, a return on equity of 8.73 percent was realized by Teva Pharmaceutical Industries. Twelve trailing months earnings per share reached a value of $0.48. Last fiscal year, Teva Pharmaceutical Industries paid $1.08 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 79.67, the P/S ratio is 1.80 and the P/B ratio is finally 1.44. The dividend yield amounts to 3.14 percent and the beta ratio has a value of 0.40.
 |
| Long-Term Stock Price Chart Of Teva Pharmaceutical Industries (TEVA) |
 |
| Long-Term Dividend Payment History of Teva Pharmaceutical Industries (TEVA) |
 |
| Long-Term Dividend Yield History of Teva Pharmaceutical Industries (TEVA) |
Ebix (NASDAQ:EBIX) has a market capitalization of $433.57 million. The company employs 1,903 people, generates revenue of $199.37 million and has a net income of $70.57 million. Ebix’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $87.18 million. The EBITDA margin is 43.73 percent (the operating margin is 38.63 percent and the net profit margin 35.40 percent).
Financial Analysis: The total debt represents 15.80 percent of Ebix’s assets and the total debt in relation to the equity amounts to 22.25 percent. Due to the financial situation, a return on equity of 20.66 percent was realized by Ebix. Twelve trailing months earnings per share reached a value of $1.74. Last fiscal year, Ebix paid $0.19 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 6.55, the P/S ratio is 2.17 and the P/B ratio is finally 1.15. The dividend yield amounts to 2.63 percent and the beta ratio has a value of 1.40.
 |
| Long-Term Stock Price Chart Of Ebix (EBIX) |
 |
| Long-Term Dividend Payment History of Ebix (EBIX) |
 |
| Long-Term Dividend Yield History of Ebix (EBIX) |
Take a closer look at the full list of predictable stocks at historical low P/B values. The average P/E ratio amounts to 22.60
and forward P/E ratio is 12.71. The dividend yield has a value of 2.93 percent.
Price to book ratio is 3.03 and price to sales ratio 3.32. The operating margin
amounts to 24.95 percent and the beta ratio is 0.91. Stocks from the list have
an average debt to equity ratio of 0.19, an extreme low value compared to the other
screens.
Here is the full table with
some fundamentals (TTM):
 |
| Proven Stocks At Historical Low P/B Ratios (Click to enlarge) |
Do you like this article? If yes, please support us and hit the button for a Facebook Like, make a tweet or post a comment in the Dividend Yield
community! Thank you so much, we really appreciate it.
Related Stock Ticker Symbols:
SNP, BVN, TEVA,
EBIX, ACN, INFY, ALTR, TECH
Selected Articles:
*I am long ACN. I receive
no compensation to write about these specific stocks, sector or theme. I don't
plan to increase or decrease positions or obligations within the next 72 hours.
For the other stocks: I
have no positions in any stocks mentioned, and no plans to initiate any
positions within the next 72 hours. I receive no compensation to write about
any specific stock, sector or theme.